Imunon Stock Quote IMNN - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.8999

Bid

0.8951

Ask

0.9131

Volume

84,811

0.872001 Day's Range 0.9142

0.48 52 Week Range 3.65

Market Cap

13.049M

Previous Close

0.898

Open

0.8834

Last Trade

500

0.8999

(formt)

Last Trade Time

Financial Volume

$ 75,516

VWAP

0.890403

Average Volume (3m)

280,348

Shares Outstanding

14,500,685

Dividend Yield

PE Ratio

-1.46

Earnings Per Share (EPS)

-1.35

Revenue

Net Profit

-19.52M

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to gen... Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. Show more

Sector

Pharmaceutical Preparations

Industry

Health Care Diversified

Website

www.imunon.com

Headquarters

Dover, Delaware, USA

Founded

1982

Imunon Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IMNN. The last closing price for Imunon was $0.90. Over the last year, Imunon shares have traded in a share price range of $ 0.48 to $ 3.65.

Imunon currently has 14,500,685 shares outstanding. The market capitalization of Imunon is $13.02 million. Imunon has a price to earnings ratio (PE ratio) of -1.46.

Form 4 - Statement of changes in beneficial ownership of securities

IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer

Company aligned with FDA on CMC strategy and requirements in preparation of Phase 3 pivotal trial of IMNN-001 Vertical integration of major components assures a high-quality, commercially viable...

IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001

Based on more than six months of additional monitoring, data show continued improvement in overall survival (OS) in intent-to-treat (ITT) population of women newly diagnosed with advanced ovarian...

Form 8-K - Current report

IMUNON Announces Results from its End-of-Phase 2 Meeting with the FDA for its Lead IMNN-001 Clinical Program in Advanced Ovarian Cancer

FDA Project Team supports the company’s proposed Phase 3 trial strategy, including overall trial design, target patient population, treatment schedule, and primary endpoint Final Protocol...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting

IMNN-001 immunotherapy plus standard-of-care chemotherapy resulted in 35% improvement in overall survival and 25% improvement in progression-free survival versus standard-of-care alone Treatment...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0075	-0.826537359489	0.9074	0.9499	0.842754	81476	0.90224588	CS
4	0.0083	0.930910722297	0.8916	1.08	0.7609	283680	0.90379048	CS
12	-0.0252	-2.72402983461	0.9251	1.08	0.64	280348	0.85860524	CS
26	-0.5001	-35.7214285714	1.4	3.65	0.64	1626761	2.61393314	CS
52	0.2109	30.6095791001	0.689	3.65	0.48	889901	2.51266162	CS
156	-1.0601	-54.0867346939	1.96	3.65	0.48	407806	2.4401708	CS
260	-1.0601	-54.0867346939	1.96	3.65	0.48	407806	2.4401708	CS

IMNN - Frequently Asked Questions (FAQ)

What is the current Imunon share price?

The current share price of Imunon is $ 0.8999

How many Imunon shares are in issue?

Imunon has 14,500,685 shares in issue

What is the market cap of Imunon?

The market capitalisation of Imunon is USD 13.02M

What is the 1 year trading range for Imunon share price?

Imunon has traded in the range of $ 0.48 to $ 3.65 during the past year

What is the PE ratio of Imunon?

The price to earnings ratio of Imunon is -1.46

What is the reporting currency for Imunon?

Imunon reports financial results in USD

What is the latest annual profit for Imunon?

The latest annual profit of Imunon is USD -19.52M

What is the registered address of Imunon?

The registered address for Imunon is 874 WALKER RD STE C, KENT, DOVER, DELAWARE, 19904

What is the Imunon website address?

The website address for Imunon is www.imunon.com

Which industry sector does Imunon operate in?

Imunon operates in the HEALTH CARE DIVERSIFIED sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BTCTBTC Digital Ltd	$ 8.2697 (73.73%)	61.45M
BDMDBaird Medical Investment Holdings Ltd	$ 8.80 (62.36%)	18.63M
CRKNCrown Electrokinetics Corporation	$ 0.1235 (54.96%)	764.86M
NUKKNukkleus Inc	$ 29.97 (45.98%)	19.09M
GSITGSI Technology	$ 3.97 (44.36%)	87.7M
DOGZDogness International Corporation	$ 18.23 (-58.77%)	740.45k
ORKTOrangeKloud Technology Inc	$ 3.02 (-24.88%)	21.08M
PMAXPowell Max Ltd	$ 0.6364 (-23.31%)	4.17M
LGCBLinkage Global Inc	$ 0.2876 (-22.27%)	890.66k
YYAIConnexa Sports Technologies Inc	$ 0.8299 (-20.20%)	602.48k
CRKNCrown Electrokinetics Corporation	$ 0.1235 (54.96%)	764.86M
GCTKGlucoTrack Inc	$ 0.0852 (15.45%)	465.22M
RIMEAlgorhythm Holdings Inc	$ 0.0406 (-4.02%)	387.23M
TGLTreasure Global Inc	$ 0.2459 (14.75%)	267.1M
NVDANVIDIA Corporation	$ 137.71 (3.10%)	201.4M